These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37530507)

  • 1.
    Hou M; Leng Y; Shi Y; Tan Z; Min X
    Am J Chin Med; 2023; 51(6):1501-1526. PubMed ID: 37530507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease.
    Bhat MA; Usman I; Dhaneshwar S
    Curr Rev Clin Exp Pharmacol; 2024; 19(3):234-249. PubMed ID: 37859409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers.
    Auyeung KK; Han QB; Ko JK
    Am J Chin Med; 2016; 44(1):1-22. PubMed ID: 26916911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic.
    Wanchaitanawong W; Thinrungroj N; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
    Int Immunopharmacol; 2022 Nov; 112():109230. PubMed ID: 36099786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.
    Rivera Rodríguez R; Johnson JJ
    Pharmacol Ther; 2023 Aug; 248():108456. PubMed ID: 37247693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polyphenols in the treatment of inflammatory bowel diseases].
    Chojnacka K; Laskowska J
    Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Aging Implications of
    Liu P; Zhao H; Luo Y
    Aging Dis; 2017 Dec; 8(6):868-886. PubMed ID: 29344421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
    Yao Y; Liu Y; Xu Q; Mao L
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Astragalus Membranaceus Active Extracts on Autophagy-related Diseases.
    Shan H; Zheng X; Li M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of polysaccharides from Astragalus membranaceus and Codonopsis pilosula ameliorated mice colitis and underlying mechanisms.
    Tang S; Liu W; Zhao Q; Li K; Zhu J; Yao W; Gao X
    J Ethnopharmacol; 2021 Jan; 264():113280. PubMed ID: 32822821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
    Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
    Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
    Alimohammadi N; Koosha F; Rafeian-Kopaei M
    Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease.
    Duan L; Cheng S; Li L; Liu Y; Wang D; Liu G
    Front Pharmacol; 2021; 12():684486. PubMed ID: 34335253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current scenario in inflammatory bowel disease: drug development prospects.
    Chandel S; Prakash A; Medhi B
    Pharmacol Rep; 2015 Apr; 67(2):224-9. PubMed ID: 25712643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of preclinical studies on the efficacy of propolis for the treatment of inflammatory bowel disease.
    Soleimani D; Miryan M; Tutunchi H; Navashenaq JG; Sadeghi E; Ghayour-Mobarhan M; Ferns GA; Ostadrahimi A
    Phytother Res; 2021 Feb; 35(2):701-710. PubMed ID: 32989885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.